Idera Pharmaceuticals’ Acquisition of Aceragen

Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals.Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there are…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now